Commission Implementing Regulation (EU) No 762/2013 of 7 August 2013 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances chlorpyrifos, chlorpyrifos-methyl, mancozeb, maneb, MCPA, MCPB and metiram (Text with EEA relevance)
Grade B
mapped from publisher markup. A grade says how a document's structure was obtained, not how reliable the law is.
Address https://gelex.eu/eli/EU/regulation/2013/762@2013-08-07/en
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC, and in particular the first paragraph of Article 17 thereof,
Whereas:
(1) Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances sets out the active substances deemed to have been approved under Regulation (EC) No 1107/2009.
(2) The approvals of the active substances chlorpyrifos, chlorpyrifos-methyl, mancozeb, maneb, MCPA, MCPB and metiram will expire between 30 April 2016 and 30 June 2016. Applications have been submitted for the renewal of the approval of these active substances. As the requirements laid down in Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market apply to those active substances, it is necessary to allow applicants sufficient time to complete the renewal procedure in accordance with that Regulation. Consequently, the approvals of those active substances are likely to expire before a decision has been taken on their renewal. It is therefore necessary to extend their approval periods.
(3) Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.
(4) In view of the aim of the first paragraph of Article 17 of Regulation (EC) No 1107/2009, as regards cases where no supplementary dossier in accordance with Implementing Regulation (EU) No 844/2012 is submitted no later than 30 months before the respective expiry date laid down in the Annex to this Regulation, the Commission will set the expiry date at the same date as before this Regulation or at the earliest date thereafter.
(5) In view of the aim of the first paragraph of Article 17 of Regulation (EC) No 1107/2009, as regards cases where the Commission will adopt a Regulation providing that the approval of an active substance referred to in the Annex to this Regulation is not renewed because the approval criteria are not satisfied, the Commission will set the expiry date at the same date as before this Regulation or at the date of the entry into force of the Regulation providing that the approval of the active substance is not renewed, whichever date is later.
(6) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,
HAS ADOPTED THIS REGULATION:
Article 1
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Article 2
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States. Done at Brussels, 7 August 2013. For the Commission The President José Manuel Barroso
ANNEX
ANNEX
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
(1) In the sixth column, expiration of approval, of row 107, MCPA, the date 30 April 2016 is replaced by 31 October 2017.
(2) In the sixth column, expiration of approval, of row 108, MCPB, the date 30 April 2016 is replaced by 31 October 2017.
(3) In the sixth column, expiration of approval, of row 111, chlorpyrifos, the date 30 June 2016 is replaced by 31 January 2018.
(4) In the sixth column, expiration of approval, of row 112, chlorpyrifos-methyl, the date 30 June 2016 is replaced by 31 January 2018.
(5) In the sixth column, expiration of approval, of row 113, maneb, the date 30 June 2016 is replaced by 31 January 2018.
(6) In the sixth column, expiration of approval, of row 114, mancozeb, the date 30 June 2016 is replaced by 31 January 2018.
(7) In the sixth column, expiration of approval, of row 115, metiram, the date 30 June 2016 is replaced by 31 January 2018.
Versions
Cited by
- Commission Implementing Regulation (EU) 2018/84 of 19 January 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances chlorpyrifos, chlorpyrifos-methyl, clothianidin, copper compounds, dimoxystrobin, mancozeb, mecoprop-p, metiram, oxamyl, pethoxamid, propiconazole, propineb, propyzamide, pyraclostrobin and zoxamide (Text with EEA relevance) Regulation · Grade B
The approval periods of the active substances chlorpyrifos, chlorpyrifos-methyl, mancozeb and metiram were extended by Commission Implementing Regulation (EU) No 762/2013. The approval periods of those substances will expire on 31 January 2018.
- Commission Implementing Regulation (EU) 2017/1511 of 30 August 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-methylcyclopropene, beta-cyfluthrin, chlorothalonil, chlorotoluron, cypermethrin, daminozide, deltamethrin, dimethenamid-p, flufenacet, flurtamone, forchlorfenuron, fosthiazate, indoxacarb, iprodione, MCPA, MCPB, silthiofam, thiophanate-methyl and tribenuron (Text with EEA relevance) Regulation · Grade B
The approval periods of the active substances MCPA and MCPB were extended by Commission Implementing Regulation (EU) No 762/2013. The approval periods of those substances will expire on 31 October 2017.
- Commission Implementing Regulation (EU) 2016/2035 of 21 November 2016 amending Implementing Regulation (EU) No 540/2011 as regards the approval periods of the active substances fipronil and maneb (Text with EEA relevance) Regulation · Grade B
The approval period of the active substance maneb was extended from 30 June 2016 until 31 January 2018 by Commission Implementing Regulation (EU) No 762/2013.
- P9_TA(2019)0099 Active substances, including dimoxystrobin and mancozeb European Parliament resolution of 18 December 2019 on the draft Commission implementing regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mancozeb, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin (D064213/02 — 2019/2925(RSP)) 2021/C 255/01 Notice · Grade B
whereas the approval period of the active substance mancozeb, which was originally due to have ended on 30 June 2016, has already been extended by 19 months by Commission Implementing Regulation (EU) No 762/2013, followed by a one-year extension by Implementing Regulation (EU) 2018/84, then another one-year extension by Implementing Regulation (EU) 2018/1796, and is now again to be extended by one year by means of this draft Commission implementing regulation, which would extend the approval period to 31 January 2021;